Wednesday, May 30, 2018

XP Dreams: Intel And Micron Diverge

The 2018 Analyst Conference presentation was very informative in a number of areas. By the end of the day last Monday, investors had many reasons to feel good about Micron��s (NASDAQ:MU) future direction and relative priorities. One area that continued to be rather opaque, however, was information pertaining to the company��s plans for exploiting 3D XPoint technology (hereafter, XP). There were subtle clues, though, and this article will discuss what these clues portend for this potentially game-changing technology.

The information we did get from Micron��s presentation revealed a widening divergence with Intel (NASDAQ:INTC), and that is pretty much a continuation of a trend that began back in 2015 with their joint introduction of XP. Since that introduction, XP has been delayed by more than two years from its original timeline and beset with ongoing dire rumors regarding its technical and financial feasibility. Despite that, Intel has never ceased aggressively hyping the technology and its potential impact on the company's bottom line. Micron, on the other hand, has been almost completely silent, revealing little other than its branding - QuantX�� - and its confidence that the new memory has great potential.

As of today, the two companies' positions could not be more starkly different. In its 2017 Investor Meeting, Intel projected up to $8 billion in XP DIMM revenue in 2021. I have attached the pertinent slide below:

Since then, Intel has announced that it will be shipping XP DIMMs in the second half of this year (CY 2018) and has doubled down on its XP manufacturing footprint in Lehi with the announcement in November 2017 of the completion of a large expansion of Building 60. What��s more, Micron announced in its Q2 earnings call that Intel loaned Micron the $500 million investment required of each of the partners in the buildout of XP production at Lehi. Pursuant to their IMFT agreement, this gives Intel to the right to more of the total share of XP production at Lehi unless/until Micron reimburses Intel at some point in the future.

Micron, on the other hand, has been almost completely silent on any projections for XP beyond the February 2016 Analysts Conference which forecasts the following:

And now, as of last week��s Analyst Conference update, here is Sanjay Mehrotra setting expectations for the commercialization of XP:

��we will be having products in 3D XPoint in 2019, launching those products in the latter part of 2019 timeframe.��

And here is Sumit Sandana in his briefing positioning the new Micron XP products:

��[...] our customers are looking forward to using 3D XPoint to expand the foot print of memory inside their servers.��

And here is Scott DeBoer giving us the latest technology update:

��Right now, the 3D XPoint technology that we��re focused on is second generation technology and that��s now moved over into manufacturing. Again, [it] combined the performance and the density that we��ve talked about several times before and improves the cost structure with the second generation of technology.��

And the final bit of information we can glean about XP was depicted in three cryptic DeBoer slides that show Micron��s expectations regarding process advances in the technology in the future. The first slide shows the current relative position of the three technologies on the performance versus cost axis.

The second slide in the series shows the relative movement on the cost axis over time:

And the final slide shows the current perspective on the end points of the current technology road map and the emergence of a ��New Memory�� technology with DRAM-like performance and cost.

So, with the combination of the companies�� actions above, we see the two partners moving in opposite directions in regard to the technology. Intel is plunging in and doubling down, while Micron hangs back and, while positive about the future potential, downplays the technology in the short run. As it stands now, Intel, while not publicly forecasting material XP revenues in 2019, is obviously expecting that the launch of XP DIMMs will ignite the business and start the company on the ramp that will take it to that $8 billion number in CY 2021.

Micron, on the other hand, because of its August fiscal year end, will not see the first revenues from XP until its FY ��20, and has yet to provide an update to its 2016 slide projections. To further dampen short-term expectations, it has even speculated that the company would be selling its share of Lehi XP production to Intel in the near term. Here��s Dave Zinsner from the Q&A session of the Q2 earnings con call:

��So 3D crosspoint products are expected to come out in - sometime in calendar year 2019. We will have - sometimes we'll have underloading charges. It's possible that our partner might take some of the - of those wafers so that would obviously help on the underutilization.��

Is there a way to explain these seemingly opposite viewpoints about a technology that both partners agree is potentially revolutionary in its impact? I believe there is, and this explanation is congruent with the expectation that XP technology will be successful. Let��s get to it.

First off, let��s be clear as we can be about what Micron is telling us about XP. The three DeBoer slides above provide a lot of information about how Micron sees XP technology advancing. The first slide shows the relative positioning of the three technologies, NAND, XP, and DRAM on a log scale graph comparing speed versus cost per bit. We��re going to talk in more detail about Micron��s DRAM roadmap in a moment, but for now, all we need to focus on is the relative positioning. Basically, XP is shown to be slightly more expensive than NAND, but is significantly faster.

Before we go further, we must remember that in the semiconductor world, the terms density and cost are interchangeable. So does Micron think that XP will increase in density over the next few years? Slide 2 answers that question in the affirmative. Note how the XP cost/bit band moves to a position almost directly over today��s NAND. That is a remarkable statement and very bullish for the future of the technology. With today��s current generation of NAND costing roughly $.10/GB, the opportunity for Micron and Intel to be extremely profitable with XP is obvious - if the density of XP can achieve the gains DeBoer is depicting, either by adding layers or by shrinking the die lithography from its current 20nm level to possibly as low as 7nm over time.

To be clear, the timing of these denser (and thus, less costly) XP technology generations is very fuzzy. If we use the DRAM generation, 1尾, as our guideline, that��s four shrinks out from this year��s 1X - 1Y, 1Z, 1伪, and finally, 1尾. So, 1尾 could be anywhere from four to six years out. The point is that these slides demonstrate that Micron clearly thinks that XP will be economic at some point, and it may give us a clue as to why Intel and Micron decided to end their NAND partnership at IM.

We know now what Micron��s NAND plans are. The company is going to charge trap technology for the Gen 4 node that will follow the last IM node, the 96-layer die. Given that the 64L technology just got to bit crossover in the last two months, that means it will be the dominant node all through 2019, leaving Gen 3 to fiscal years 2020 through 2021 in which it will be fully productive and cost-effective. Given that cadence, Micron will probably be introducing CT Gen 4 sometime in 2021 in anticipation of full production sometime in FY 2022.

Is it possible that Intel feels it doesn��t need another NAND node because it can increase XP densities enough to be an attractive alternative to NAND? We don��t know for sure, because Intel has not announced its post Gen 3 roadmap. We do have clarity on Micron��s position, though. The company is confident that the CT-based 3D NAND technology has the potential to advance to 200+ layers, and that means NAND will remain the economic choice for storage architectures well into the mid-20��s, if not longer.

Let��s pause for a moment here to recap. Here��s what we know or can infer:

Intel and Micron are parting ways on NAND. The last IM node, the Gen 3 96L die, will be highly competitive, if not market-leading, in cost through FY 2020 and much of FY 2021. Intel is planning for $8 billion of XP revenue in CY 2021. Micron won��t see any revenue from XP until its FY ��20. Micron has ceded much of its XP output from Lehi to Intel, at least until it pays back the $500 million loan from Intel used to fund the Building 60 expansion at Lehi. Micron has announced a DRAM technology roadmap that has four generations beyond the current ��1X�� node. Intel has not announced its post-Gen 3 3D NAND technology roadmap. Micron��s recent analyst meeting technology futures slides indicate that the company thinks that XP will get significantly more dense over the course of the next four to six years.

So what can Micron investors take away from all this? Here��s my take on it, for what it��s worth:

Micron has concluded that DRAM has at least a four to six-year runway, whether XP is successful or not. The company feels it has a viable business in 3D NAND over the foreseeable future (well into the mid-2020��s). The company thinks that it can have a viable XP business in FY ��20 and beyond, but has not characterized the size or potential scope of that business. Micron thinks that XP has a serious potential to impact the growth of the DRAM business by the mid-2020��s.

Of the above, point #1 is the key to Micron��s business results through FY 2021. Micron will remain a DRAM company and will rise (or fall) depending on the health of the DRAM market. If I had to speculate about Micron��s current strategic outlook, my view is that the company sees the DRAM business at this point as a reliably growing cash cow that can be depended on for the foreseeable future. The company does feel that XP will be viable, and at some point XP will potentially impact DRAM demand - but that time is four to five years away at the earliest.

A skeptic could challenge my position by asking - if Micron is so bullish on DRAM, why has it not announced a new DRAM fab? To which I would answer:

That would be the wrong signal to send to the Koreans regarding industry capacity management. Micron probably feels that such a fab - which, if it were to be announced at the upcoming Q3 earnings call, would not be in full production until 2020 - would have some or all of its capacity stranded by 2025, when it is still not fully through its 7-year depreciation cycle. The company is going to need its CapEx dollars to either build its own or contribute to another IM XP fab in the 2020 time frame.

In closing, my take on this is that Micron��s opacity on XP becomes much less opaque when we understand the implications of the company's announcement that it sees at least four more DRAM generations in its development plans. Whatever happens with XP in the short term, the DRAM market will remain robust and highly profitable, driving Micron��s profits and cash flow into record-setting territory over the course of the next few years. Intel may or may not succeed in the short term, but its success or lack thereof will have no material effect on Micron. Over the longer term, post 2020, Micron is poised to win big with XP once Intel has done all the pioneering work establishing the market. Heads (XP fails or is slow in market development) Micron wins, tails (XP is a big success) it wins bigger.

Remember, I say Micron, you say DRAM - for the next few years, at any rate.

Long MU.

Disclosure: I am/we are long MU, NVDA, WDC, PSTG.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Tuesday, May 29, 2018

Consumer Discretionary SPDR (XLY) is Cavalier Investments LLC’s 5th Largest Position

Cavalier Investments LLC lifted its stake in shares of Consumer Discretionary SPDR (NYSEARCA:XLY) by 67.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 184,419 shares of the exchange traded fund’s stock after buying an additional 74,598 shares during the quarter. Consumer Discretionary SPDR makes up approximately 6.6% of Cavalier Investments LLC’s portfolio, making the stock its 5th biggest position. Cavalier Investments LLC owned 0.15% of Consumer Discretionary SPDR worth $18,680,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the company. Dow Chemical Co. DE lifted its stake in Consumer Discretionary SPDR by 111.9% in the fourth quarter. Dow Chemical Co. DE now owns 90,451 shares of the exchange traded fund’s stock valued at $8,927,000 after buying an additional 47,757 shares during the last quarter. UBS Asset Management Americas Inc. lifted its stake in Consumer Discretionary SPDR by 5.7% in the fourth quarter. UBS Asset Management Americas Inc. now owns 266,677 shares of the exchange traded fund’s stock valued at $26,318,000 after buying an additional 14,421 shares during the last quarter. Advisor Partners LLC lifted its stake in Consumer Discretionary SPDR by 59.3% in the fourth quarter. Advisor Partners LLC now owns 4,092 shares of the exchange traded fund’s stock valued at $432,000 after buying an additional 1,523 shares during the last quarter. Raymond James & Associates lifted its stake in Consumer Discretionary SPDR by 8.6% in the fourth quarter. Raymond James & Associates now owns 550,954 shares of the exchange traded fund’s stock valued at $54,374,000 after buying an additional 43,486 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its stake in Consumer Discretionary SPDR by 114.8% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 78,755 shares of the exchange traded fund’s stock valued at $7,772,000 after buying an additional 42,086 shares during the last quarter.

Get Consumer Discretionary SPDR alerts:

Consumer Discretionary SPDR traded up $0.16, hitting $106.13, during trading hours on Friday, Marketbeat Ratings reports. The stock had a trading volume of 3,840,941 shares, compared to its average volume of 6,318,200. Consumer Discretionary SPDR has a 1-year low of $87.89 and a 1-year high of $109.34.

Consumer Discretionary SPDR Company Profile

Consumer Discretionary Select Sector SPDR Fund seeks to provide investment results that correspond generally to the price and yield performance of the Consumer Discretionary Select Sector Index (the Index). The Index includes companies from the following industries, media; retail (specialty, multiline, Internet and catalog); hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure equipment and products; and diversified consumer services.

Institutional Ownership by Quarter for Consumer Discretionary SPDR (NYSEARCA:XLY)

Saturday, May 26, 2018

Hot Undervalued Stocks To Buy Right Now

tags:LB,GSK,EPIX,INOD,EEFT,RM,

Primecap Management Company is an under-the-radar adviser that doesn’t talk to the media. But it did something no other tracked fund did: it bought Tesla for less than $30 a share in 2011 and hung on to it through the stock’s explosion this year. That’s an estimated gain of 469%.

Primecap advises the Odyssey Funds, which consist of a stock fund, growth fund and aggressive growth fund. Its investment profile reads like that of most typical value advisers, looking to uncover undervalued stocks whose fundamentals will develop beyond Wall Street’s expectations. With a long-term approach, the managers identify changes in a company that could increase value in three-to-five years, such as new products or management, and then wait.

NEW YORK, NY - APRIL 04: A Tesla car is displayed in a showroom at a Brooklyn Tesla dealership on April 4, 2017 in New York City. As of Monday, the start-up car maker founded by Elon Musk had passed iconic car manufacture Ford in market value, riding a 7 percent share-value surge to a market capitalization of about $48.7 billion. (Photo by Spencer Platt/Getty Images)

Hot Undervalued Stocks To Buy Right Now: L Brands, Inc.(LB)

Advisors' Opinion:
  • [By Logan Wallace]

    L Brands (NYSE:LB) had its target price decreased by MKM Partners to $38.00 in a research note published on Friday. MKM Partners currently has a neutral rating on the specialty retailer’s stock.

  • [By Paul Ausick]

    L Brands Inc. (NYSE: LB) traded down about 10% Thursday and posted a new 52-week low of $30.70 after closing Wednesday at $34.12. The stock’s 52-week high is $63.10. Volume totaled around 14 million, about three times the daily average of around 4.5 million. The company warned that profits would we lower than expected when it reports quarterly results on May 23.

  • [By Chris Lange]

    L Brands Inc. (NYSE: LB) will report its most recent quarterly results on Wednesday. The consensus estimates are $2.04 in EPS and $4.73 billion in revenue. Shares were last seen trading at $48.71, in a 52-week range of $35.00 to $63.10. The consensus price target is $54.04.

  • [By Chris Lange]

    L Brands Inc. (NYSE: LB) will report its most recent quarterly results on Wednesday. The consensus estimates call for $0.18 in EPS and $2.59 billion in revenue. Shares were last seen trading at $33.74, in a 52-week range of $30.70 to $63.10. The consensus price target is $44.83.

  • [By ]

    1. L Brands (NYSE: LB)
    This female-focused retailer is leading the retail apocalypse. Shares have been crushed this year by plunging over 40% in the last four months.� Already suffering from the overall retail malaise, L Brands exasperated the downside by issuing weak guidance at the end of 2017. Combined with analyst downgrades, the stock only collapsed under the pressure. �

  • [By Taylor Cox]

    Notable Earnings

    Tiffany & Co. (NYSE: TIF) Q1 premarket Ralph Lauren Corporation (NYSE: RL) Q4 premarket Target Corporation (NYSE: TGT) Q1 premarket Lowe’s Companies, Inc (NYSE: LOW) Q1 premarket L Brands, Inc (NYSE: LB) Q1 after hours NetApp, Inc (NASDAQ: NTAP) Q4 after hours

    IPOs

Hot Undervalued Stocks To Buy Right Now: GlaxoSmithKline PLC(GSK)

Advisors' Opinion:
  • [By ]

    In the Lightning Round, Cramer was bullish on Walgreens Boots Alliance (WBA) , Arena Pharmaceuticals (ARNA) , Dominion Energy (D) , Idexx Laboratories (IDXX) , GlaxoSmithKline (GSK) , Baidu.com (BIDU) , Baozun (BZUN) and Alibaba (BABA) .

  • [By Joseph Griffin]

    FDx Advisors Inc. cut its position in shares of GlaxoSmithKline (NYSE:GSK) by 24.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 92,124 shares of the pharmaceutical company’s stock after selling 30,211 shares during the period. FDx Advisors Inc.’s holdings in GlaxoSmithKline were worth $3,599,000 at the end of the most recent quarter.

  • [By ]

    GlaxoSmithKline (GSK) : "I like Glaxo. I think they're doing a fantastic job."

    LexinFintech Holdings Ltd.  (LX) : "The only ones I'm recommending from China are Baidu.com (BIDU) , Alibaba (BABA) and Baozun (BZUN) ."

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    Whether ExxonMobil can rebound or not isn't a question we will try to answer in this space today. Instead, here are three dividend stocks with higher yields -- and what these Motley Fool investors think are better prospects -- than ExxonMobil:�Bladex�(NYSE:BLX),�Enbridge Inc. (USA) (NYSE:ENB), and�GlaxoSmithKline plc (ADR)�(NYSE:GSK).�

  • [By Cory Renauer]

    Around a year ago, the partners launched an eczema drug that's already surpassed Praluent on the sales charts, and a possible expansion to asthma could send Dupixent sales through the roof.�In studies supporting an application under review at the moment, Dupixent reduced severe attacks by up to 67% for some patients with uncontrolled asthma. It also led to lung function measurements that suggest it can compete with GlaxoSmithKline's (NYSE:GSK)�Nucula for a slice of a global market for asthma treatments expected to reach $56.5 billion by 2025.

  • [By Cory Renauer]

    GlaxoSmithKline's (NYSE:GSK) launch of Shingrix,�a new shingles vaccine that contains a proprietary booster licensed from Agenus, is progressing well, with first-quarter sales topping $150 million.�A second vaccine aimed at malaria could be on the way, as well.

Hot Undervalued Stocks To Buy Right Now: ESSA Pharma Inc.(EPIX)

Advisors' Opinion:
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Losers Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday. Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81. Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections. Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results. LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss. Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit. Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings. Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss. Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight. Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings. The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results. Arcadia Biosciences, Inc. (N

Hot Undervalued Stocks To Buy Right Now: Innodata Inc.(INOD)

Advisors' Opinion:
  • [By Stephan Byrd]

    Innodata (NASDAQ:INOD) will be releasing its Q1 2018 earnings data before the market opens on Tuesday, May 8th.

    Innodata (NASDAQ:INOD) last announced its earnings results on Thursday, March 8th. The technology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $15.66 million for the quarter. Innodata had a negative return on equity of 10.94% and a negative net margin of 8.30%.

  • [By Stephan Byrd]

    Media coverage about Innodata (NASDAQ:INOD) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innodata earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 47.3485759085159 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Hot Undervalued Stocks To Buy Right Now: Euronet Worldwide Inc.(EEFT)

Advisors' Opinion:
  • [By Asit Sharma]

    Electronic payments and remittances giant�Euronet Worldwide (NASDAQ:EEFT)�displayed crisp revenue growth in its earnings report issued April 25, which covered the first three months of the current year. Below, we'll outline summary numbers, delve into pertinent details underlying the results, and review management's perspective on the quarter:

  • [By Ethan Ryder]

    Euronet Worldwide (NASDAQ: EEFT) and Payment Data Systems (NASDAQ:PYDS) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Euronet Worldwide (EEFT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks To Buy Right Now: Regional Management Corp.(RM)

Advisors' Opinion:
  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Regional Management (RM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Provident Financial (OTCMKTS: FPLPY) and Regional Management (NYSE:RM) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.

Friday, May 25, 2018

Goldman Sachs Group (GS) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Goldman Sachs Group (NYSE:GS) from a strong-buy rating to a hold rating in a report released on Tuesday morning.

According to Zacks, “Shares of Goldman underperformed the industry over the past six months. However, the company boasts an impressive earnings surprise history. It surpassed the Zacks Consensus Estimate for earnings in all the trailing four quarters. The company’s first-quarter 2018 results witnessed top-line strength. Strong trading activities on high volatility supported the bottom-line numbers. Though regulatory issues are concerns, we believe the company’s well-diversified business and focus to capitalize on growth opportunities through strategic moves will continue to strengthen the overall business. Further, its cost-control measures are commendable. Additionally, the company’s steady capital-deployment activities have boosted investors' confidence. Notably, longtime CEO of Goldman is likely to retire by the end of 2018.”

Get Goldman Sachs Group alerts:

GS has been the topic of several other reports. Wells Fargo & Co reissued an outperform rating and issued a $320.00 target price on shares of Goldman Sachs Group in a report on Thursday, January 25th. Morgan Stanley boosted their target price on Goldman Sachs Group from $294.00 to $297.00 and gave the stock an overweight rating in a report on Friday, February 2nd. Vetr raised Goldman Sachs Group from a sell rating to a hold rating and set a $246.36 target price on the stock in a report on Thursday, February 8th. Bank of America reissued a buy rating and issued a $300.00 target price (up from $249.30) on shares of Goldman Sachs Group in a report on Monday, February 12th. Finally, JPMorgan Chase & Co. reissued a buy rating and issued a $280.00 target price on shares of Goldman Sachs Group in a report on Thursday, March 15th. Three investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and ten have issued a buy rating to the company. Goldman Sachs Group presently has an average rating of Hold and a consensus price target of $266.78.

GS stock opened at $236.10 on Tuesday. Goldman Sachs Group has a 1-year low of $209.62 and a 1-year high of $275.31. The company has a market capitalization of $89.83 billion, a PE ratio of 11.95, a P/E/G ratio of 0.82 and a beta of 1.38. The company has a debt-to-equity ratio of 3.12, a quick ratio of 0.92 and a current ratio of 0.92.

Goldman Sachs Group (NYSE:GS) last released its quarterly earnings data on Tuesday, April 17th. The investment management company reported $6.95 earnings per share for the quarter, beating the consensus estimate of $5.58 by $1.37. Goldman Sachs Group had a return on equity of 12.58% and a net margin of 14.27%. The company had revenue of $10.04 billion for the quarter, compared to analyst estimates of $8.73 billion. During the same period in the prior year, the company posted $5.15 EPS. The company’s revenue was up 25.0% compared to the same quarter last year. analysts forecast that Goldman Sachs Group will post 23.27 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 28th. Shareholders of record on Thursday, May 31st will be issued a dividend of $0.80 per share. This is an increase from Goldman Sachs Group’s previous quarterly dividend of $0.75. The ex-dividend date of this dividend is Wednesday, May 30th. This represents a $3.20 annualized dividend and a yield of 1.36%. Goldman Sachs Group’s dividend payout ratio is currently 15.18%.

In other news, insider David M. Solomon sold 3,497 shares of the stock in a transaction on Tuesday, May 15th. The stock was sold at an average price of $244.40, for a total value of $854,666.80. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.57% of the stock is currently owned by corporate insiders.

Several hedge funds have recently bought and sold shares of GS. Icon Wealth Partners LLC acquired a new position in shares of Goldman Sachs Group in the 4th quarter valued at $113,000. Cerebellum GP LLC acquired a new position in shares of Goldman Sachs Group in the 4th quarter valued at $122,000. Prime Capital Investment Advisors LLC bought a new stake in shares of Goldman Sachs Group in the 4th quarter valued at $127,000. We Are One Seven LLC bought a new stake in shares of Goldman Sachs Group in the 4th quarter valued at $137,000. Finally, Crewe Advisors LLC increased its position in shares of Goldman Sachs Group by 65.5% in the 1st quarter. Crewe Advisors LLC now owns 581 shares of the investment management company’s stock valued at $146,000 after buying an additional 230 shares in the last quarter. 72.42% of the stock is currently owned by institutional investors.

Goldman Sachs Group Company Profile

The Goldman Sachs Group, Inc operates as an investment banking, securities, and investment management company worldwide. It operates through four segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Management. The Investment Banking segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, spin-offs, and risk management; and underwriting services, such as debt and equity underwriting of public offerings and private placements of various securities and other financial instruments, as well as derivative transactions with public and private sector clients.

Get a free copy of the Zacks research report on Goldman Sachs Group (GS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Goldman Sachs Group (NYSE:GS)

Thursday, May 24, 2018

Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Cemex (CX) Share Price

Media headlines about Cemex (NYSE:CX) have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cemex earned a news sentiment score of 0.10 on Accern’s scale. Accern also assigned news coverage about the construction company an impact score of 44.7310435870588 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

Get Cemex alerts: Global White Cement Market 2018 Evaluation- Cemex, JKCL, Lafarge, Cementir Holding, Cimsa and Sotacib (exclusivereportage.com) CEMEX, SAB de CV (CX) Stock Price trades -22.96% off from 200- SMA (nasdaqchronicle.com) Tottering Stocks: CEMEX, SAB de CV (NYSE:CX), My Size, Inc. (NASDAQ:MYSZ), Emerge Energy Services LP (NYSE … (thestreetpoint.com) Investor Radar CEMEX, SAB de CV (CX) moves -43.39% away from 52-Week High (nasdaqchronicle.com) These Stocks: Will Rock You: CEMEX, SAB de CV (NYSE:CX), Marrone Bio Innovations, Inc. (NASDAQ:MBII … (thestreetpoint.com)

Shares of Cemex traded up $0.02, reaching $6.03, during trading on Tuesday, Marketbeat reports. 5,467,715 shares of the company were exchanged, compared to its average volume of 9,993,179. The firm has a market cap of $8.57 billion, a PE ratio of 14.71, a price-to-earnings-growth ratio of 0.58 and a beta of 1.39. Cemex has a 12-month low of $5.72 and a 12-month high of $10.37. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.52 and a current ratio of 0.73.

Cemex (NYSE:CX) last issued its earnings results on Thursday, April 26th. The construction company reported $0.02 EPS for the quarter, missing the Zacks’ consensus estimate of $0.05 by ($0.03). The company had revenue of $3.38 billion for the quarter. Cemex had a return on equity of 4.33% and a net margin of 3.58%. equities research analysts predict that Cemex will post 0.6 EPS for the current fiscal year.

A number of analysts recently weighed in on CX shares. Barclays reduced their price objective on shares of Cemex from $11.00 to $10.00 and set an “overweight” rating on the stock in a research report on Friday, March 16th. Zacks Investment Research lowered shares of Cemex from a “hold” rating to a “sell” rating in a research report on Friday, May 4th. Bank of America raised shares of Cemex from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $8.00 to $8.50 in a research report on Monday, April 9th. They noted that the move was a valuation call. ValuEngine lowered shares of Cemex from a “hold” rating to a “sell” rating in a research report on Friday, April 6th. Finally, UBS lowered shares of Cemex from a “buy” rating to a “sell” rating and reduced their price objective for the stock from $7.62 to $6.50 in a research report on Thursday, February 15th. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $9.34.

Cemex Company Profile

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, clinker, and other construction materials. The company also offers various complementary construction products, including asphalt products; concrete blocks and roof tiles; architectural products; concrete pipes for storm and sanitary sewers applications; and other precast products comprising rail products, concrete floors, box culverts, bridges, drainage basins, barriers, and parking curbs.

Insider Buying and Selling by Quarter for Cemex (NYSE:CX)

Sunday, May 20, 2018

Apple Hospitality REIT (APLE) Shares Bought by Riverhead Capital Management LLC

Riverhead Capital Management LLC grew its position in Apple Hospitality REIT (NYSE:APLE) by 607.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 134,100 shares of the real estate investment trust’s stock after acquiring an additional 115,150 shares during the quarter. Riverhead Capital Management LLC owned about 0.06% of Apple Hospitality REIT worth $2,356,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. US Bancorp DE boosted its holdings in shares of Apple Hospitality REIT by 132.3% in the fourth quarter. US Bancorp DE now owns 5,479 shares of the real estate investment trust’s stock valued at $107,000 after acquiring an additional 3,120 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Apple Hospitality REIT by 20.4% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,566 shares of the real estate investment trust’s stock valued at $364,000 after acquiring an additional 3,147 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in shares of Apple Hospitality REIT by 10.9% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 33,366 shares of the real estate investment trust’s stock valued at $586,000 after acquiring an additional 3,286 shares during the period. Daiwa Securities Group Inc. boosted its holdings in shares of Apple Hospitality REIT by 14.6% in the first quarter. Daiwa Securities Group Inc. now owns 26,700 shares of the real estate investment trust’s stock valued at $469,000 after acquiring an additional 3,400 shares during the period. Finally, Public Employees Retirement Association of Colorado boosted its holdings in shares of Apple Hospitality REIT by 67.7% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 11,071 shares of the real estate investment trust’s stock valued at $217,000 after acquiring an additional 4,468 shares during the period. 56.86% of the stock is owned by institutional investors and hedge funds.

Get Apple Hospitality REIT alerts:

Several equities research analysts recently weighed in on APLE shares. Barclays started coverage on Apple Hospitality REIT in a report on Wednesday, January 31st. They set an “equal weight” rating and a $21.00 price target for the company. TheStreet downgraded Apple Hospitality REIT from a “b” rating to a “c” rating in a report on Thursday, February 8th. B. Riley set a $20.00 price target on Apple Hospitality REIT and gave the stock a “hold” rating in a report on Friday, February 23rd. Robert W. Baird set a $20.00 price target on Apple Hospitality REIT and gave the stock a “buy” rating in a report on Monday, February 26th. Finally, Zacks Investment Research downgraded Apple Hospitality REIT from a “hold” rating to a “sell” rating in a report on Wednesday, February 28th. Six research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Apple Hospitality REIT currently has an average rating of “Hold” and an average target price of $20.00.

Shares of Apple Hospitality REIT opened at $18.39 on Friday, according to MarketBeat.com. The company has a debt-to-equity ratio of 0.14, a current ratio of 0.06 and a quick ratio of 0.06. Apple Hospitality REIT has a 1-year low of $16.72 and a 1-year high of $20.19. The firm has a market cap of $4.21 billion, a P/E ratio of 10.57, a P/E/G ratio of 2.10 and a beta of 0.64.

Apple Hospitality REIT (NYSE:APLE) last issued its quarterly earnings results on Monday, May 7th. The real estate investment trust reported $0.18 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.21). Apple Hospitality REIT had a return on equity of 5.38% and a net margin of 15.30%. The company had revenue of $298.40 million for the quarter, compared to analyst estimates of $299.89 million. During the same period in the prior year, the business earned $0.39 earnings per share. Apple Hospitality REIT’s revenue for the quarter was up 1.9% compared to the same quarter last year. sell-side analysts predict that Apple Hospitality REIT will post 1.75 earnings per share for the current fiscal year.

The business also recently declared a monthly dividend, which was paid on Tuesday, May 15th. Investors of record on Wednesday, May 2nd were issued a dividend of $0.10 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.53%. The ex-dividend date was Tuesday, May 1st. Apple Hospitality REIT’s dividend payout ratio is presently 68.97%.

In other Apple Hospitality REIT news, insider Glade M. Knight acquired 10,000 shares of the business’s stock in a transaction on Thursday, March 8th. The stock was purchased at an average price of $17.16 per share, for a total transaction of $171,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Glade M. Knight acquired 5,800 shares of the business’s stock in a transaction on Wednesday, February 28th. The stock was acquired at an average price of $17.10 per share, with a total value of $99,180.00. Following the transaction, the chairman now directly owns 10,052,157 shares of the company’s stock, valued at approximately $171,891,884.70. The disclosure for this purchase can be found here. Insiders acquired 38,504 shares of company stock valued at $665,862 in the last quarter. 6.30% of the stock is currently owned by company insiders.

About Apple Hospitality REIT

Apple Hospitality REIT, Inc (NYSE: APLE) is a publicly traded real estate investment trust (REIT) that owns one of the largest portfolios of upscale, select-service hotels in the United States. The Company's highly diversified portfolio consists of 241 hotels with more than 30,500 guest rooms located in 88 markets throughout 34 states.

Institutional Ownership by Quarter for Apple Hospitality REIT (NYSE:APLE)